Autres langues OPC Pharmaceutical

Actions

OPC

VN000000OPC9

Produits pharmaceutiques

Cours en clôture Ho Chi Minh S.E. 21/08/2026			Varia. 5j.	Varia. 1 janv.
21 000,00 ^VND	0,00%		-0,94%	+2,38%

31/07	OPC Pharmaceutical Joint Stock Company publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
07/07	OPC Pharmaceutical Joint Stock Company annonce des changements au sein de ses comités, effectifs au 2 juillet 2026	CI

Autres langues

31/07	OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
20/07	Opc Pharmaceutical Joint Stock Company Receives Tax Authority Fine of VND 22,000,000 for Late Submission of Natural Resource Tax Returns
07/07	OPC Pharmaceutical Joint Stock Company Announces Committee Changes, Effective July 2, 2026
26/06	OPC Pharmaceutical Joint Stock Company Receives Approval for the Termination of Operations of Nghe an Branch
29/04	Opc Pharmaceutical Joint Stock Company Announces Board Changes, Effective April 25, 2026
28/04	OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026
06/04	OPC Pharmaceutical Joint Stock Company announces Annual dividend, payable on July 20, 2026
30/01	OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
26/10/25	OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
24/07/25	OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
28/04/25	OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2025
24/01/25	OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024
23/10/24	OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
30/07/24	OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
13/05/24	Opc Pharmaceutical Joint Stock Company Appoints Nong Thi Lan as Member of the Internal Audit Committee
06/05/24	OPC Pharmaceutical Joint Stock Company Approves Cash Dividend for the Year 2023, Payable on May 21, 2024
02/05/24	OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024
30/01/24	OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
05/12/23	OPC Pharmaceutical Joint Stock Company Receives the Resignation from Duong Minh Hung as Sales and Marketing Deputy Chief Executive Officer
30/10/23	OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
29/08/23	OPC Pharmaceutical Joint Stock Company Appoints Mrs. Nguyen Thi Hong the Person in Charge of Corporate Governance Cum Secretary
31/07/23	OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
25/05/23	OPC Pharmaceutical Joint Stock Company Announces the Resignation of Le Van Son as Chairman of the BOD
08/05/23	OPC Pharmaceutical Joint Stock Company Announces the Remaining Cash Dividend in 2023, Payable on May 25, 2023
05/05/23	Opc Pharmaceutical Joint Stock Company Announces Executive Changes